In today’s environment, IP strategy directly impacts valuation, funding, and exit outcomes. Rising costs, increased scrutiny, and real-world enforcement challenges are forcing companies to rethink how they manage and invest in their patent portfolios.

This month’s member meeting explores the 2026 equity capital markets outlook, examining investment trends shaping life sciences and medical devices and what healthcare leaders need to know to navigate the year ahead.

This month’s member meeting explores the 2026 equity capital markets outlook, examining investment trends shaping life sciences and medical devices and what healthcare leaders need to know to navigate the year ahead.